Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes
October 2, 2025
Initiative spans an IVD assay and a new Revvity Omics lab-developed test to expand clinical testing for early-stage disease screening Revvity, Inc. announced a program